Hydroxyurea
Cat.No:IH0150 Solarbio
CAS:127-07-1
Molecular Formula:CH4N2O2
Molecular Weight:76.05
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
HydroxyureaCAS:127-07-1
Molecular Formula:CH4N2O2
Molecular Weight:76.05
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 127-07-1 |
Name | Hydroxyurea |
Molecular Formula | CH4N2O2 |
Molecular Weight | 76.05 |
Solubility | Soluble in Water/DMSO |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 204-821-7 |
MDL | MFCD00007943 |
SMILES | O=C(N)NO |
InChIKey | VSNHCAURESNICA-UHFFFAOYSA-N |
InChI | InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) |
PubChem CID | 3657 |
Target Point | DNA/RNA Synthesis |
Passage | Cell Cycle;DNA Damage/DNA Repair |
Background | Hydroxyurea is an apoptosis inducer that inhibits DNA synthesis by inhibiting ribonucleotide reductase. |
Biological Activity | Hydroxyurea是通过抑制核糖核苷酸还原酶抑制DNA合成的细胞凋亡诱导剂。[1-4] |
Data Literature Source | [1]. Kovacic P,et al. Hydroxyurea (therapeutics and mechanism): metabolism,carbamoyl nitroso,nitroxyl,radicals,cell signaling and clinical applications. Med Hypotheses. 2011 Jan;76(1):24-31. [2]. Watanapokasin Y,et al. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Exp Hematol. 2005 Dec;33(12):1486-92. [3]. Lori F,et al. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug. Clin Infect Dis. 2000 Jun;30 Suppl 2:S193-7. [4]. Lebensburger JD,et al. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model. Haematologica. 2010 Sep;95(9):1599-603. |
Unit | Bottle |
Specification | 50mg 100mg 10mM*1mL in DMSO |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Hydroxyurea ameliorates atherosclerosis in ApoE-/- mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota
Click to check >>Author:Yang XY; Yu H; Fu J; Guo HH; Han P; Ma SR; Pan LB;
IF:10.6680
Publish_to:Theranostics
PMID:36451858